Li et al found that miR-144-3p could arrest pancreatic cancer cells in the S phase of the cell cycle by activating the mitogen-activated protein kinase pathway, and its inhibitory effect on pancreatic cancer cell proliferation could be reversed using miR-144-3p inhibitors [43]. This evidence concerns the gene WNK2 and pancreatic neoplasm.